PSA testing is a key tool in detecting prostate issues early, but interpreting results requires context. Levels can rise from cancer or other benign conditions, so follow-up tests are often needed.

These substantial increases highlight the growing financial burden on patients undergoing necessary diagnostic testing following an abnormal PSA test. Out-of-pocket costs (OOPCs) for diagnostic ...

Prostate cancer overdiagnosis occurs when a person is diagnosed with prostate cancer through PSA testing – even though that ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study We conducted a nested case-control study among men age 40 to 59 years who gave blood ...